Literature DB >> 2833724

Point mutation in the polyomavirus enhancer alters local DNA conformation.

F K Fujimura1.   

Abstract

A point mutation in the enhancer of polyomavirus host range mutant, PyEC F441, permits productive infection of the murine embryonal carcinoma cell line, F9. This mutation at nucleotide position 5258 introduces a local conformational change in naked viral DNA. The effect of all four possible nucleotide sequences at position 5258 on local DNA conformation was analyzed by gel electrophoresis of fragments produced by ligation of synthetic oligonucleotides having these sequences. The results indicated that both the wild-type and the F441 sequences introduced local structural polymorphism that can lead to DNA bending. The wild-type sequence had a greater effect on DNA curvature than the F441 sequence. The two other sequences at nucleotide 5258 did not appear to introduce detectable amounts of DNA curvature.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833724      PMCID: PMC338194          DOI: 10.1093/nar/16.5.1987

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  39 in total

1.  A factor discriminating between the wild-type and a mutant polyomavirus enhancer.

Authors:  I Kovesdi; M Satake; K Furukawa; R Reichel; Y Ito; J R Nevins
Journal:  Nature       Date:  1987 Jul 2-8       Impact factor: 49.962

2.  Sequence-induced DNA curvature at the bacteriophage lambda origin of replication.

Authors:  K Zahn; F R Blattner
Journal:  Nature       Date:  1985 Oct 3-9       Impact factor: 49.962

3.  An exonuclease protection assay reveals heat-shock element and TATA box DNA-binding proteins in crude nuclear extracts.

Authors:  C Wu
Journal:  Nature       Date:  1985 Sep 5-11       Impact factor: 49.962

4.  Cooperative binding of lambda repressors to sites separated by integral turns of the DNA helix.

Authors:  A Hochschild; M Ptashne
Journal:  Cell       Date:  1986-03-14       Impact factor: 41.582

5.  Physical characterization of a kinetoplast DNA fragment with unusual properties.

Authors:  J C Marini; P N Effron; T C Goodman; C K Singleton; R D Wells; R M Wartell; P T Englund
Journal:  J Biol Chem       Date:  1984-07-25       Impact factor: 5.157

6.  Mutation near the polyoma DNA replication origin permits productive infection of F9 embryonal carcinoma cells.

Authors:  F K Fujimura; P L Deininger; T Friedmann; E Linney
Journal:  Cell       Date:  1981-03       Impact factor: 41.582

7.  The nucleotide sequence and restriction enzyme sites of the polyoma genome.

Authors:  P L Deninger; A Esty; P LaPorte; H Hsu; T Friedmann
Journal:  Nucleic Acids Res       Date:  1980-02-25       Impact factor: 16.971

8.  Expression of polyoma early functions in mouse embryonal carcinoma cells depends on sequence rearrangements in the beginning of the late region.

Authors:  M Katinka; M Yaniv; M Vasseur; D Blangy
Journal:  Cell       Date:  1980-06       Impact factor: 41.582

9.  Sequence dependence of the curvature of DNA: a test of the phasing hypothesis.

Authors:  P J Hagerman
Journal:  Biochemistry       Date:  1985-12-03       Impact factor: 3.162

10.  Bent DNA at a yeast autonomously replicating sequence.

Authors:  M Snyder; A R Buchman; R W Davis
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

View more
  3 in total

1.  Curved DNA without A-A: experimental estimation of all 16 DNA wedge angles.

Authors:  A Bolshoy; P McNamara; R E Harrington; E N Trifonov
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

2.  A single-stranded DNA binding protein binds the origin of replication of the duplex kinetoplast DNA.

Authors:  D Avrahami; Y Tzfati; J Shlomai
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

3.  Genetic analysis of the enhancer requirements for polyomavirus DNA replication in mice.

Authors:  R Rochford; B A Campbell; L P Villarreal
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.